Skip to Content

Logo 01A (Aggrenox 25 mg / 200 mg)

Generic Name: aspirin/dipyridamole

Pill imprint Logo 01A has been identified as Aggrenox 25 mg / 200 mg.

Aggrenox is used in the treatment of ischemic stroke, prophylaxis and belongs to the drug class platelet aggregation inhibitors. There is positive evidence of human fetal risk during pregnancy. Aggrenox 25 mg / 200 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).

Aggrenox 25 mg / 200 mg Logo 01A
Aggrenox 25 mg / 200 mg Logo 01A
Aggrenox 25 mg / 200 mg Logo 01A  Front
Aggrenox 25 mg / 200 mg Logo 01A  Back
Generic Name:
Logo 01A
25 mg / 200 mg
Red & White
24.00 mm
Prescription only
Drug Class:
Platelet aggregation inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Boehringer Ingelheim Pharmaceuticals, Inc.
National Drug Code (NDC):
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-5143 Physicians Total Care Inc (repackager)
68258-9022 Dispensing Solutions Inc. (repackager)
49999-0919 Lake Erie Medical and Surgical Supply (repackager)
21695-0656 Rebel Distributors Corp (repackager)

Note: Inactive ingredients may vary.

View Details Print Page Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.